Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Short-term Investments (2019 - 2021)

Bio Key International's Short-term Investments history spans 3 years, with the latest figure at $512821.0 for Q2 2021.

  • For Q2 2021, Short-term Investments changed 0.0% year-over-year to $512821.0; the TTM value through Jun 2021 reached $512821.0, changed 0.0%, while the annual FY2020 figure was $512821.0, 0.0% changed from the prior year.
  • Short-term Investments for Q2 2021 was $512821.0 at Bio Key International, roughly flat from $512821.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $516121.0 in Q3 2020 and bottomed at $512821.0 in Q4 2019.
  • The 3-year median for Short-term Investments is $512821.0 (2019), against an average of $513292.4.
  • The largest YoY upside for Short-term Investments was 0.0% in 2020 against a maximum downside of 0.0% in 2020.
  • A 3-year view of Short-term Investments shows it stood at $512821.0 in 2019, then changed by 0.0% to $512821.0 in 2020, then changed by 0.0% to $512821.0 in 2021.
  • Per Business Quant, the three most recent readings for BKYI's Short-term Investments are $512821.0 (Q2 2021), $512821.0 (Q1 2021), and $512821.0 (Q4 2020).